All News Telo Genomics Corp. Toronto S.E.

Equities

TELO

CA87975M1095

End-of-day quote Toronto S.E. Other stock markets			5-day change	1st Jan Change
- ^PTS	-.--%		-.--%	-.--%

Apr. 10	Telo Genomics Receives Accreditation from College of American Pathologists	MT
Apr. 10	Telo Genomics Corp. Receives Accreditation from College of American Pathologists	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Telo Genomics Receives Accreditation from College of American Pathologists	Apr. 10	MT
Telo Genomics Receives Accreditation from College of American Pathologists	Apr. 10	NE
Telo Genomics Corp. Receives Accreditation from College of American Pathologists	Apr. 10	CI
Telo Genomics' MRD Clinical Trial Expands into Multi-Center Trial; Shares up 9.5%	Apr. 02	MT
Telo Genomics' Flagship MRD Clinical Trial Expands into Multi-Center Trial	Apr. 02	NE
Telo Genomics Corp. Announces Patient Recruitment for Its Minimal Respiratory Disease Clinical Trial Has Been Initiated, with Several Patient Samples Received and Processed to Date	Apr. 02	CI
Telo Genomics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 27	CI
Telo Genomics Corp. Initiates MRD Clinical Trial for Multiple Myeloma Patients	Feb. 13	CI
Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients	Feb. 13	NE
Telo Genomics Engages US Diagnostics Experts to Power Product Adoption in the US	Jan. 30	NE
Telo Genomics Corp. Announces Executive Changes	Dec. 08	CI
Telo Genomics Gears up for American Society of Hematology Conference	Dec. 06	NE
Telo Genomics Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 22	CI
Telo Genomics Launches Physician Experience Program in the United States	Nov. 16	NE
Telo Genomics Advances to the Final Stage of Accreditation from The College of American Pathologists	Nov. 07	NE
Telo Genomics Corp. Announces the American Society of Hematology Accepts the Results of Teloview-Smm Technical Repeatability Validation for Presentation At Their Annual Meeting in December 10, 2023	Nov. 01	CI
American Society of Hematology (ASH) Accepts Validation Data from Telo Genomics for Presentation at Upcoming Annual Meeting	Nov. 01	NE
Telo Genomics Corp. Reports Earnings Results for the Full Year Ended June 30, 2023	23-10-30	CI
Telo Genomics : Consolidated Financial Statements	23-10-29	PU
Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation	23-10-26	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Telo Genomics Corp. Toronto S.E.

Equities

TELO

CA87975M1095

All News

Filters